Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
BACKGROUND AND OBJECTIVE: Tuberculosis is the most dangerous infectious disease in the world today. Rifampicin (RMP) and Isoniazid (INH) are the two most important first-line anti-tuberculosis drugs for the treatment of tuberculosis. Resistance to these drugs has been increased in most of countries....
Saved in:
Main Authors: | M Pourhajibagher, M Nasrollahi, SR Musavi, B Rahimi-Esboei, A Ghorbani Pashakolaei |
---|---|
Format: | article |
Language: | EN FA |
Published: |
Babol University of Medical Sciences
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/7a3acb9c5a264b3f83edfd7ddaab2e28 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis
by: Zomorodbakhsh S, et al.
Published: (2020) -
Detection of serum isoniazid concentration in patients with multidrug-resistant tuberculosis using high-performance liquid chromatography
by: M. K. Vinokurova, et al.
Published: (2018) -
How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers
by: Qianhui Hua, et al.
Published: (2021) -
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain
by: Hakkimane SS, et al.
Published: (2018) -
Detección de mutaciones asociadas a cepas multidrogo resistente de Mycobacterium tuberculosis en Chile
by: Araya,Pamela, et al.
Published: (2011)